Speaker Profile
Ph.D., VP of Business Development, SeqOne
Biography
Michael Vishnevetsky is a seasoned commercial leader with extensive experience scaling companies in the genomics, diagnostics, and precision oncology space. Throughout his career, Michael has built high-impact strategic alliances and led commercial teams at industry-leading companies including Fabric Genomics, Personal Genome Diagnostics, and Invivoscribe. He brings a deep expertise in biopharma partnerships and companion diagnostics strategy, helping to connect innovative technologies with clinical and pharmaceutical partners.
Talk
Streamlining Precision Oncology: Flexible Pipelines for CGP Liquid Biopsy
This session introduces a next-generation, end-to-end bioinformatics solution for today's CGP and liquid biopsy labs. We demonstrate how this unified platform streamlines the entire analytical workflow, from raw FASTQ data to comprehensive report. We'll highlight the software's flexible architecture, which empowers labs to adapt to diverse assays, scale operations, and accelerate precision oncology.
AI for Clinical Decision Support Systems Showcase:
SeqOne
SeqOne is a leading European provider of AI-powered software for NGS data analysis in oncology and rare diseases. The cloud platform is HIPAA compliant and CE-IVD Class C certified. It transforms complex genomic data into fast, actionable insights, supporting molecular labs in delivering life-saving personalized treatments and scaling genomic medicine for every patient, everywhere.
Session Abstract – PMWC 2026 Silicon Valley
"The PMWC 2026 AI for Clinical Decision Support Showcase will provide a 15-30 minute time slot for selected organizations, including commercial companies, clinical testing labs, and medical research institutions, to present their latest advancements, insights, applications, and technologies to an audience of clinicians, leading investigators, academic institutions, pharma and biotech, investors, and potential clients. We will learn about new technologies and findings that promise expedited, cost-effective, and accurate clinical diagnosis for early disease detection, treatment decisions, and disease prevention.
- Clinical Dx/Oncology (including Liquid Biopsy)
- Clinical Dx/Cardio Vascular
- Clinical Dx/Neurodegenerative
